TY - JOUR
T1 - Myasthenia in SCID mice grafted with myasthenic patient lymphocytes role of CD4+ and CD8+ cells
AU - Wang, Zeng Yu
AU - Karachunski, Peter I.
AU - Howard, James F.
AU - Conti-Fine, Bianca M.
PY - 1999/2
Y1 - 1999/2
N2 - Objectives: Acetylcholine receptor (AChR)-specific CD4+ cells are present in MG patients, and syNthesis of the high-affinity immunoglobulin G (IgG) autoantibodies (autoAb) against the muscle AChR that causes MG symptoms requires intervention of CD4+ cells. The role of CD4+ cells in MG pathogenesis has been postulated but never proven. MG patients do not have anti-AChR cytotoxic phenomena, and it has been assumed that CD8+ cells do not have a pathogenic role in MG. However, CD8+ cells may facilitate rodent experimental MG, raising the possibility that CD8+ cells might be necessary also in MG. In this study we examined whether CD4+ and CD8+ cells play a role in the pathogenesis of MG and whether CD4+ cells specific for AChR epitope sequences recognized by most MG patients ('universal' epitopes) drive the synthesis of pathogenic antibodies. Methods: First we characterized a chimetic human-mouse model of MG in severe combined immunodeficiency (SCID) mice engrafted with blood lymphocytes (BL) from MG patients. We used that model to determine whether CD4+ and CD8+ cells are necessary for transfer of MG symptoms. We engrafted SCID mice intraperitoneum with BL from 19 MG patients and 5 healthy controls. We engrafted some mice with either BL, BL depleted in CD4+ or CD8+ cells from the same patient, or CD4+ depleted BL reconstituted with CD4+ T cells from the same patient, specific for 'universal' AChR epitopes or for two unrelated antigens, tetanus and diphtheria toxoids. We tested the mice for myasthenic symptoms for 7 to 18 weeks. Results: Mice transplanted with BL, or CD8+ depleted BL, or CD4+- depleted BL reconstituted with anti-AChR CD4+ cells from MG patients frequently developed myasthenic weakness. The mice had human anti-AChR Ab in the serum and bound to muscle AChR. Mice transplanted with BL from controls, or CD4+-depleted BL from MG patients, or CD4+-depleted BL from an MG patient reconstituted with CD4+ cells specific for tetanus or diphtheria toxoids did not develop myasthenic weakness or anti-AChR Ab. Conclusions: CD4+ cells are necessary for MG pathogenesis; CD8+ cells may not be. CD4+ cells specific for 'universal' AChR epitopes help the synthesis of pathogenic Ab.
AB - Objectives: Acetylcholine receptor (AChR)-specific CD4+ cells are present in MG patients, and syNthesis of the high-affinity immunoglobulin G (IgG) autoantibodies (autoAb) against the muscle AChR that causes MG symptoms requires intervention of CD4+ cells. The role of CD4+ cells in MG pathogenesis has been postulated but never proven. MG patients do not have anti-AChR cytotoxic phenomena, and it has been assumed that CD8+ cells do not have a pathogenic role in MG. However, CD8+ cells may facilitate rodent experimental MG, raising the possibility that CD8+ cells might be necessary also in MG. In this study we examined whether CD4+ and CD8+ cells play a role in the pathogenesis of MG and whether CD4+ cells specific for AChR epitope sequences recognized by most MG patients ('universal' epitopes) drive the synthesis of pathogenic antibodies. Methods: First we characterized a chimetic human-mouse model of MG in severe combined immunodeficiency (SCID) mice engrafted with blood lymphocytes (BL) from MG patients. We used that model to determine whether CD4+ and CD8+ cells are necessary for transfer of MG symptoms. We engrafted SCID mice intraperitoneum with BL from 19 MG patients and 5 healthy controls. We engrafted some mice with either BL, BL depleted in CD4+ or CD8+ cells from the same patient, or CD4+ depleted BL reconstituted with CD4+ T cells from the same patient, specific for 'universal' AChR epitopes or for two unrelated antigens, tetanus and diphtheria toxoids. We tested the mice for myasthenic symptoms for 7 to 18 weeks. Results: Mice transplanted with BL, or CD8+ depleted BL, or CD4+- depleted BL reconstituted with anti-AChR CD4+ cells from MG patients frequently developed myasthenic weakness. The mice had human anti-AChR Ab in the serum and bound to muscle AChR. Mice transplanted with BL from controls, or CD4+-depleted BL from MG patients, or CD4+-depleted BL from an MG patient reconstituted with CD4+ cells specific for tetanus or diphtheria toxoids did not develop myasthenic weakness or anti-AChR Ab. Conclusions: CD4+ cells are necessary for MG pathogenesis; CD8+ cells may not be. CD4+ cells specific for 'universal' AChR epitopes help the synthesis of pathogenic Ab.
UR - http://www.scopus.com/inward/record.url?scp=0033044909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033044909&partnerID=8YFLogxK
U2 - 10.1212/wnl.52.3.484
DO - 10.1212/wnl.52.3.484
M3 - Article
C2 - 10025776
AN - SCOPUS:0033044909
SN - 0028-3878
VL - 52
SP - 484
EP - 497
JO - Neurology
JF - Neurology
IS - 3
ER -